Meningococcemia Recognition and Management

Clinical Presentation

The British Medical Journal recommends that patients with suspected meningococcemia be identified by their non-specific symptoms, including fever, lethargy, irritability, nausea, poor feeding, myalgias, and arthralgias, which can last several hours before progressing to fulminant disease 1
Leg pain, cold extremities, and abnormal skin color are particularly associated with developing invasive disease 1
A generalized petechial rash beyond the distribution of the superior vena cava, or purpuric rash in any location in an ill patient, is strongly suggestive of meningococcemia 1
Signs of septicemia, present in approximately 20% of cases, include fever with rapidly evolving rash 2, signs of shock: hypotension, tachycardia, cold extremities, prolonged capillary refill (>2 seconds) 3

The British Medical Journal recommends immediate administration of intramuscular benzylpenicillin (or ceftriaxone if available) in the outpatient setting upon suspicion of meningococcemia, without delay for investigations or confirmatory tests 1
The Journal of Infection suggests that patients require assessment by a senior clinician within the first hour of hospital arrival 2, 4
Supportive care during transfer should include maintaining airway, breathing, circulation, administering oxygen if available 3, keeping the patient warm (avoiding hypothermia) 2, and monitoring vital signs continuously if possible 4

The British Medical Journal advises against sending patients home for reassessment, as half of all children with meningococcal disease are sent home at first presentation, and treatment should be initiated immediately upon suspicion 5
The Journal of Infection recommends against delaying antibiotics for diagnostic procedures, as most deaths occur within the first 24 hours, often before specialist care begins, and treatment delay increases mortality 2
The British Medical Journal suggests that early antibiotic administration before hospital admission, while lacking randomized trial evidence, is widely advocated and makes clinical sense given the rapid progression of disease 5